David Cole to Radiotherapy Dosage
This is a "connection" page, showing publications David Cole has written about Radiotherapy Dosage.
Connection Strength
0.035
-
Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):837-44.
Score: 0.028
-
Combined surgery and radiotherapy for conservative management of soft tissue sarcomas. Recent Results Cancer Res. 1995; 138:47-55.
Score: 0.007